Conference Information
A “veteran of Zhangjiang’s Pharmaceutical Valley” and his firsthand account of two decades of innovative drug development in China

A “veteran of Zhangjiang’s Pharmaceutical Valley” and his firsthand account of two decades of innovative drug development in China

Mar 29,2026

On Perseverance, Transformation, and Expectation
CPIC 2026 | Junlian Capital & Rxilient Special Session: Global Expansion of Pharmaceutical Companies and Collaboration in Emerging Markets

CPIC 2026 | Junlian Capital & Rxilient Special Session: Global Expansion of Pharmaceutical Companies and Collaboration in Emerging Markets

Mar 29,2026

Legend Capital, Rxilient, and TONACEA are jointly hosting a special session themed "Global Development of Pharmaceutical Enterprises and Emerging Market Collaboration." The session will focus on the latest policies, market opportunities and challenges, product and industry go-to-market strategies, and localization practices in Southeast Asia, the Middle East and North Africa, and Latin America.
AI-Driven Drug Discovery Ushers in “China’s Moment”

AI-Driven Drug Discovery Ushers in “China’s Moment”

Mar 28,2026

Standing in the spotlight, waiting
Innovation is shifting eastward—where does regulation stand?

Innovation is shifting eastward—where does regulation stand?

Mar 27,2026

The United States and China in the New World Order
Multinational Pharmaceutical Companies Are “Increasing Their Positions” in China

Multinational Pharmaceutical Companies Are “Increasing Their Positions” in China

Mar 25,2026

A Vote of Confidence Worth Over Hundreds of Billions
8 Billion in M&A Within Two Days: China’s Innovative Drugs Are Becoming Global “Hard Currency”

8 Billion in M&A Within Two Days: China’s Innovative Drugs Are Becoming Global “Hard Currency”

Mar 25,2026

Making Its Way to the Center of the Global Stage
Chinese Pharmaceutical Companies “Challenge” the World’s Most Expensive

Chinese Pharmaceutical Companies “Challenge” the World’s Most Expensive

Mar 24,2026

Full-Scale Pursuit
The Inaugural CNS Innovative Drug R&D Conference Is Here | CPIC Global Conference

The Inaugural CNS Innovative Drug R&D Conference Is Here | CPIC Global Conference

Mar 23,2026

As the inaugural featured conference, The 1st CNS Innovative Drug R&D Conference is co-hosted by TONACEA, Hanshu Bio, and Quark Pharma. Focusing on the high-value, high-potential sector of CNS drug development, the conference brings together top R&D experts from around the world to decode emerging CNS targets and mechanisms, clinical development, gene editing, and other key technologies. It will feature in-depth discussions on cutting-edge topics such as the treatment of CNS diseases and global registration strategies for innovative drugs, aiming to establish a professional exchange platform for R&D innovation, clinical translation, industrial collaboration, and global partnership in the CNS field.
< 1...19202122 > proceed page

Follow or Contact Us

Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.

Official Account QR Code

Public Account QR Code

Registration QR Code

Registration QR Code

Conference Service Hotline

+86 010 8363 4290

© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.

Powered by：CEglobal

Image Name
Image Name
Image Name
Image Name
Image Name